Hundreds of EPA Workers Leave the Agency

Buyouts offered to more than 1,200 Environmental Protection Agency employees prompted the surge in departures.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, KRBLOKHINBuyouts offered by the Trump administration to more than 1,200 Environmental Protection Agency (EPA) employees have prompted 400 people to leave their posts since the end of last month, The Wall Street Journal reports. This mass exit has resulted in a 2.5 percent cut in the agency’s staff, the report states, and if workers continue to take the buyouts, the EPA could be facing its smallest operating staff since the late 1980s.

The majority of the deals presented to employees consisted of buyouts or voluntary early retirement for eligible employees, according to an E&E News report from earlier this summer (July 17). The number of EPA employees offered either deal was expected to tally up to 1,227 workers for this summer, with the EPA’s Office of Research and Development hit the hardest by a potential loss of 183 workers. Those who choose to opt into the summer buyouts will have to do so by September 2 of this year, E&E reports.

According to The Wall Street Journal, it’s not yet known which EPA departments the departures affected most.

“We’re proud to report that we’re reducing the size of government, protecting taxpayer dollars and staying true to our ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery